A 12-Week Study Comparing Pitavastatin 4 mg vs. Pravastatin 40 mg in HIV-Infected Subjects

NCT01301066 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

252

Enrollment

INDUSTRY

Sponsor class

Conditions

Dyslipidemia

Interventions

DRUG: Pitavastatin
DRUG: Pravastatin

Sponsor

Kowa Research Institute, Inc.

Collaborators

[object Object]
[object Object]